Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of 24-hours Versus 72-hours of Octreotide Infusion Along With Endoscopic Therapy in Preventing Early Rebleed From Esophageal Varices: a Multi-center, Randomized Clinical Study

NCT03624517 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03624517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03624517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of 24-hours Versus 72-hours of Octreotide Infusion Along With Endoscopic Therapy in Preventing Early Rebleed From Esophageal Varices: a Multi-center, Randomized Clinical Study
Lead sponsor
Medical University of South Carolina
Phase
Phase 4
Overall status
Terminated
Start date
September 19, 2018
Completion date
December 1, 2024
Enrollment
34 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding esophageal varices, esophageal varices, liver cirrhoses, upper gastrointestinal bleeding